Aligos Therapeutics ALGS
NASDAQ ALGS
$5.03 +0.00 (+0.10%)
As of: Oct 21, 2026 · 9:38 AM EDT

Aligos Therapeutics (ALGS) Receivables - Net (2026)

Updated

Aligos Therapeutics (ALGS) posted Receivables - Net of $27.78 million for Q2 2026.

Analysis

Aligos Therapeutics (ALGS) Receivables - Net (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,140.41 Bn 1,108.99 Bn 19.71 Bn
2 Johnson & Johnson 618.57 Bn 537.10 Bn 17.26 Bn
3 AbbVie 509.95 Bn 483.06 Bn 12.70 Bn
4 Merck 366.63 Bn 321.01 Bn 12.21 Bn
5 Novartis Ag 298.47 Bn 262.46 Bn 11.24 Bn
6 Astrazeneca 263.21 Bn 236.89 Bn 12.86 Bn
7 Amgen 236.71 Bn 192.11 Bn 7.24 Bn
8 Gilead Sciences 193.05 Bn 167.25 Bn 6.22 Bn
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn
10 Aligos Therapeutics 52.52 Mn -275.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.78 Mn
API Access

Aligos Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=ALGS&period=max&api_key=YOUR_API_KEY